Abstract
Background
Endolymphatic sac tumour (ELST) is a rare low-grade locally aggressive neoplasm arising from the endolymphatic duct or sac. It presents mostly with vestibulo-cochlear symptoms either sporadically or as part of von Hippel–Lindau (VHL) syndrome. Micro-neurosurgical excision remains the cornerstone of therapy with the role of radiotherapy (RT) being controversial. This is a clinico-pathological analysis of consecutive ELST patients presenting to a single-institution in India.
Methods
Neuropathology database of a tertiary-care comprehensive cancer centre was searched electronically to identify consecutive patients with histopathological diagnosis of ELST registered at the institute over last one decade. Data regarding demographic profile, clinical presentation, histopathological features, treatment details and outcomes were retrieved from electronic medical records for this retrospective analysis.
Results
Electronic search identified seven unique patients with biopsy-proven ELST registered at the institute between 2009 and 2020. Median age of the study cohort was 39 years (range 24–65 years) with strong male predilection (5:2 ratio) and left-sided preponderance (71%). Most common presenting symptoms were hearing loss (86%) and earache (71%) on affected side followed by headache (43%). All patients underwent maximal safe resection at initial diagnosis and were followed-up closely with periodic surveillance imaging. Two patients underwent salvage RT using high-precision conformal techniques at recurrence/progression.
Conclusion
ELST is a rare low-grade locally aggressive neoplasm that arises generally as part of VHL syndrome or sometimes sporadically. Gross total resection provides the best chance of cure with RT being reserved for unresectable disease, large residue, medical inoperability, or as salvage therapy for recurrent/progressive tumor.
Similar content being viewed by others
References
Hassard AD, Boudreau SF, Cron CC (1984) Adenoma of the endolymphatic sac. J Otolaryngol 13(4):213–216
Heffner DK (1989) Low-grade adenocarcinoma of probable endolymphatic sac origin A clinicopathologic study of 20 cases. Cancer 64(11):2292–2302
Mendenhall WM, Suárez C, Skálová A, Strojan P, Triantafyllou A, Devaney KO et al (2018) Current treatment of endolymphatic sac tumor of the temporal bone. Adv Ther 35(7):887–898
Guo F, Zhang L, Mo L (2020) Long experience for the diagnosis and treatment of sporadic endolymphatic sac tumor in a single center. Clin Neurol Neurosurg 197:106078
Bausch B, Wellner U, Peyre M, Boedeker CC, Hes FJ, Anglani M et al (2016) Characterization of endolymphatic sac tumors and von Hippel-Lindau disease in the International Endolymphatic Sac Tumor Registry. Head Neck 38(Suppl 1):E673-679
Zanoletti E, Girasoli L, Borsetto D, Opocher G, Mazzoni A, Martini A (2017) Endolymphatic sac tumour in von Hippel-Lindau disease: management strategies. Acta Otorhinolaryngol Ital 37(5):423–429
Li JC, Brackmann DE, House JW, Lo WWM, Carberry JN (1993) Reclassification of aggressive adenomatous mastoid neoplasms as endolymphatic sac tumors. Laryngoscope 103(12):1342–1348
El-Naggar AK, Chan JKC, Grandis JR (2017) Tumours of the ear. In: Takata T, Slootweg PJ (eds) WHO classification of head and neck tumours, 4th edn. IARC Press, Lyon, pp 261–273
Poletti AM, Dubey SP, Colombo G, Cugini G, Mazzoni A (2016) Treatment of endolymphatic sac tumour (papillary adenocarcinoma) of the temporal bone. Rep Pract Oncol Radiother 21(4):391–394
Jegannathan D, Kathirvelu G, Mahalingam A (2016) Three sporadic cases of endolymphatic sac tumor. Neurol India 64(6):1336
Rajeshwari B, Shanmugam S, Sadiya N, Mitra G, Chendilnathan B (2019) “Endolymphatic sac tumour”: a case report with review of literature. Indian J Pathol Microbiol 62(4):608
Mukherji SK, Albernaz VS, Lo WW, Gaffey MJ, Megerian CA, Feghali JG et al (1997) Papillary endolymphatic sac tumors: CT, MR imaging, and angiographic findings in 20 patients. Radiology 202(3):801–808
Le H, Zhang H, Tao W, Lin L, Li J, Ma L et al (2019) Clinicoradiologic characteristics of endolymphatic sac tumors. Eur Arch Otorhinolaryngol 276(10):2705–2714
Baltacioğlu F, Ekinci G, Türe U, Sav A, Pamýr N, Erzen C (2002) MR imaging, CT, and angiography features of endolymphatic sac tumors: report of two cases. Neuroradiology 44(1):91–96
Nevoux J, Nowak C, Vellin J-F, Lepajolec C, Sterkers O, Richard S et al (2014) Management of endolymphatic sac tumors: sporadic cases and von Hippel-Lindau disease. Otol Neurotol 35(5):899–904
Friedman RA, Hoa M, Brackmann DE (2013) Surgical management of endolymphatic sac tumors. J Neurol Surg Part B Skull Base 74(1):12–19
Ferri E, Amadori M, Armato E, Pavon I (2014) A rare case of endolymphatic sac tumour: clinicopathologic study and surgical management. Case Rep Otolaryngol 2014:376761
Bambakidis NC, Megerian CA, Ratcheson RA (2004) Differential grading of endolymphatic sac tumor extension by virtue of von Hippel-Lindau disease status. Otol Neurotol 25(5):773–781
Schipper J, Maier W, Rosahl SK, van Velthoven V, Berlis A, Boedeker CC et al (2006) Endolymphatic sac tumours: surgical management. J Otolaryngol 35(6):387–394
Li F, Zhang Y, Li W, Wu Q, Kong D, Shi X et al (2020) Grading system and surgical approaches for endolymphatic sac tumors. Eur Arch Otorhinolaryngol. https://doi.org/10.1007/s00405-020-06185-3
Sykopetrites V, Piras G, Giannuzzi A, Caruso A, Taibah A, Sanna M (2020) The endolymphatic sac tumor: challenges in the eradication of a localized disease. Eur Arch Otorhinolaryngol. https://doi.org/10.1007/s00405-020-06323-x
Totten DJ, Manzoor NF, Sherry AD, Khattab MH, Link MJ, Cmelak AJ et al (2020) Radiotherapy and radiosurgery for treatment of residual or recurrent endolymphatic sac tumor following previous microsurgical resection. Otol Neurotol 41(6):e759-762
Wick CC, Eivaz NA, Yeager LH, Hunter JB, Isaacson B, Kutz JW (2018) Case series and systematic review of radiation outcomes for endolymphatic sac tumors. Otol Neurotol 39(5):550–557
Tay KY, Yu E, Kassel E (2007) Spinal metastasis from endolymphatic sac tumor. Am J Neuroradiol 28(4):613–614
Sinclair G, Al-Saffar Y, Brigui M, Martin H, Bystam J, Benmakhlouf H et al (2018) Gamma knife radiosurgery in the management of endolymphatic sac tumors. Surg Neurol Int 9:18
Kempermann G, Neumann HPH, Volk B (1998) Endolymphatic sac tumours. Histopathology 33(1):2–10
Thompson LDR, Magliocca KR, Andreasen S, Kiss K, Rooper L, Stelow E et al (2019) CAIX and pax-8 commonly immunoreactive in endolymphatic sac tumors: a clinicopathologic study of 26 cases with differential considerations for metastatic renal cell carcinoma in von Hippel-Lindau Patients. Head Neck Pathol 13:355–363
Taverna C, Pollastri F, Pecci R, Giannoni B, Fattorini C, Santucci M et al (2020) Papillary-cystic neoplasms of the middle ear are distinct from endolymphatic sac tumours. Histopathology. https://doi.org/10.1111/his.14250
Horiguchi H, Sano T, Toi H, Kageji T, Hirokawa M, Nagahiro S (2001) Endolymphatic sac tumor associated with a Von Hippel-Lindau disease patient: an immunohistochemical study. Mod Pathol 14(7):727–732
Wang H-Q, Jie L, Shi H-Y (2018) Clinicopathological features of low-grade malignant endolymphatic sac tumors. Pathol Res Pract 214(3):431–435
Acknowledgements
Brain Tumor Foundation (BTF) of India.
Funding
No source of funding was involved in this retrospective case series.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None of the authors have any conflicts to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Talukdar, R., Epari, S., Sahay, A. et al. Endolymphatic sac tumor: single-institution series of seven cases with updated review of literature. Eur Arch Otorhinolaryngol 279, 2591–2598 (2022). https://doi.org/10.1007/s00405-021-07047-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-021-07047-2